Translational Development Acquisition (TDACW) Cash & Equivalents Growth (1y) (2024 - 2026)
Powered by 
Analysis
Translational Development Acquisition (TDACW) Cash & Equivalents Growth (1y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Evercore | 11.52 Bn | 9.43 Bn | 975.67 Mn | 103.56% |
| 2 | Jefferies Financial | 11.24 Bn | -4.17 Bn | 3.09 Bn | - |
| 3 | Houlihan Lokey | 9.53 Bn | 8.45 Bn | - | 22.45% |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 5 | PJT Partners | 6.94 Bn | 6.99 Bn | 481.98 Mn | 9.75% |
| 6 | Moelis | 6.06 Bn | 5.99 Bn | - | 25,932.58% |
| 7 | Piper Sandler Companies | 5.20 Bn | 5.09 Bn | - | 146.69% |
| 8 | Lazard | 4.97 Bn | 3.99 Bn | - | 12.42% |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn | -61.93% |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - | 143.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.59% |
| Mar 31, 2026 | -88.08% |
| Dec 31, 2025 | -93.20% |
| Dec 31, 2024 | 21,581.05% |